Can You Spot Axial Spondyloarthritis?
The PCP’s Role in Timely Recognition and Referral
eBook Reader
 |
Clinical Recommendations and Tools
2016 Update of the ASAS-EULAR Management Recommendations for Axial Spondyloarthritis.
van der Heijde D, et al. Ann Rheum Dis. 2017;0:1-14.
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM, et al. Arthritis Rheumatol. 2016;68(2):282-298.
The SIMPLE (Screening for InflaMmatory Back Pain in the LowEr) Back Questionnaire.
Canadian Research and Education (CaRE), 2012.
Ankylosing Spondylitis Disease Activity Score (ASDAS; online calculator).
Assessment of Spondyloarthritis International Society (ASAS).
Suggested Readings
Ankylosing spondylitis diagnosis in US patients with back pain: Identifying providers involved and factors associated with rheumatology referral delay.
Deodhar A, et al. Clin Rheumatol.
Evaluation of multiple referral strategies for axial spondyloarthritis in the SPondyloArthritis Caught Early (SPACE) cohort.
Abawi O, et al. RMD Open. 2017;3(1):e000389.
Gender-attributable differences in outcome of ankylosing spondylitis: Long-term results from the Outcome in Ankylosing Spondylitis International Study.
Webers C, et al. Rheumatology (Oxford). 2016;55(3):419-428.
Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts.
Ez-Zaitouni Z, et al. Arthritis Res Ther. 2017;19(1):118.
MRI evidence of structural changes in the sacroiliac joints of patients with nonradiographic axial spondyloarthritis even in the absence of MRI inflammation.
Maksymowych WP, et al. Arthritis Res Ther. 2017;19:126.
Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey.
Ramonda R, et al. Arthritis Res Ther. 2016;18:78.
The journey to diagnosis of AS/AxSpA: The impact of delay.
Martindale J, Goodacre L. Musculoskeletal Care. 2014;12(4):221-231.
The prevalence and clinical characteristics of nonradiographic axial spondyloarthritis among patients with inflammatory back pain in rheumatology practices: A multinational, multicenter study.
Burgos-Varga R, et al. Arthritis Res Ther. 2016;18:132.
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.
Smolen JS, et al. Ann Rheum Dis. 2017. [Epub ahead of print].
Patient-Education Resources
Welcome to the Spondyloarthritis Community.
Spondylitis Association of America, 2017.
The Spondylitis Association of America (SAA) is a nonprofit organization founded in 1983 to address the needs of people living with spondylitis. This site includes an inflammatory back pain quiz, disease education, and links to numerous patient-support resources.
Spondyloarthritis.
American College of Rheumatology, 2013.
This patient-oriented site addresses frequently asked questions regarding spondyloarthritis.
Spondyloarthritis.
Arthritis Foundation.
This site provides a succinct overview of spondyloarthritis causes, symptoms, diagnosis, treatment, and self-care.
The PCP’s Role in Timely Recognition and Referral
Relevant Resources
Balancing the Benefits and Risk of Opioid-Based Therapy
Individualized Assessment and Mechanism-Based Multimodal Treatment
Responsible Opioid Prescribing to Achieve Individualized Functional Goals
Overcoming Pain and Gastrointestinal Distress to Improve Patient Outcomes
Proactive Diagnosis and Targeted Management
Selecting Patients and Optimizing Long-Term Outcomes
Evidence-Based Strategies for Improved Patient Outcomes
Proactive Diagnosis and Targeted Management
Differential Diagnosis and Comprehensive Management Strategies
Optimizing Maintenance Therapy Across Healthcare Settings
Evolving Strategies for Diagnosis and Long-Term Management
Consensus and Controversies for Responsible Opioid Prescribing
Best Practices in Combination Therapy
The Role of Nurses in Optimizing Long-term Outcomes
Evolving Approaches to Insulin Based Therapy
Evolving Best-Practice Strategies to Maximize Efficacy and Safety
Improving Outcomes for Patients with COPD
New Strategies for Insulin Replacement Therapy
Clinical Updates in LDL-C Management
Improving Comprehensive Patient Care
Identifying Patients and Tailoring Therapy
Collaborative Approaches to Guideline-Concordant Patient Care
New Strategies for Individualizing Long-term Care
A Focus on Patients With Opioid-Induced Constipation
Consensus and Controversies Across the Spectrum of Patient Presentations
Evolving Treatment Algorithms and Expert Perspectives on Biosimilars
Patient Selection, Treatment Initiation, and Ongoing Monitoring
Engaging With Patients About Opioid-Induced Constipation
Evolving Best Practices to Optimize Outcomes
Debates and Discussions About Therapeutically Targeting Nerve Growth Factor Signaling
Differential Diagnosis, Multidisciplinary Management, and Patient Engagement
Key Issues Impacting OB/GYN Practice
Expanding the Conversation on Opioid-Induced Constipation
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
Translating Guidelines Into Patient Care
Improving Patient Outcomes Through Shared Clinical Decision Making
Mechanistic Insights and Evolving Treatment Options
Clinical Resource Center
A Case-Based Conversation on Managing Asthma and Chronic Rhinosinusitis With Nasal Polyposis
The Clinical and Utilization Benefits of Exacerbation Prevention
A PrEP Primer
A Foundation for Managed Care
Cardiovascular and Renal Outcomes With SGLT2 Inhibitors
Best Practices for Primary Care
New Paths to Chronic Pain Management
What the Pharmacist Needs to Know about PrEP
Unlocking Novel Paths to Patient Care
The Increasing Role of JAK Inhibitors
Preventing COPD Exacerbations to Improve Outcomes
A Whole Patient Case Series
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
